Clarivate to Acquire DRG

Article

Applied Clinical Trials

Clarivate Analytics plc has announced it has signed a definitive agreement to acquire Decision Resources Group. The $950 million purchase price, includes $900 million in cash and approximately $50 million in Clarivate ordinary shares to be issued following the one-year anniversary of closing.

For more details on this acquisition, click here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.